Hepatocellular CarcinomaPhase 1NCT05003895
CAR-T cell
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
10 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Liver and bile duct10 studies
Hepatocellular CarcinomaPhase 1NCT05003895
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Unresectable Fibrolamellar CarcinomaPhase 1/2NCT04380545Papers
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Liver CancerPhase 1NCT04715191
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Refractory Pediatric Solid TumorsPhase 1/2NCT05468359
Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Hepatocellular Carcinoma (HCC)Phase 1NCT07075120Papers
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
Untreated Advanced Biliary Tract CancerPhase 1NCT07107750
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
Unresectable Hepatocellular CarcinomaPhase 1NCT05488522
SBRT With Atezo/Bev for HCC
Unresectable Hepatocellular CarcinomaPhase 1NCT05096715
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
Advanced Biliary Tract CancerPhase 1NCT06546969
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
Fibrolamellar Hepatocellular Carcinoma (FLC)Phase 1NCT04248569Papers
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma